Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence

about

Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence

Item

http://www.wikidata.org/entity/Q57486707

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Baclofen for the Treatment of ...... Years After the First Evidence

@en

Baclofen for the Treatment of ...... Years After the First Evidence

@nl

type

Item

label

Baclofen for the Treatment of ...... Years After the First Evidence

@en

Baclofen for the Treatment of ...... Years After the First Evidence

@nl

prefLabel

Baclofen for the Treatment of ...... Years After the First Evidence

@en

Baclofen for the Treatment of ...... Years After the First Evidence

@nl

P1476

Baclofen for the Treatment of ...... Years After the First Evidence

@en

P2093

Alberto Tosoni

http://www.w3.org/2001/XMLSchema#string

Antonio Gasbarrini

http://www.w3.org/2001/XMLSchema#string

Antonio Mirijello

http://www.w3.org/2001/XMLSchema#string

Carolina Mosoni

http://www.w3.org/2001/XMLSchema#string

Claudia Tarli

http://www.w3.org/2001/XMLSchema#string

Gabriele Angelo Vassallo

http://www.w3.org/2001/XMLSchema#string

Giovanni Addolorato

http://www.w3.org/2001/XMLSchema#string

Luisa Sestito

http://www.w3.org/2001/XMLSchema#string

Maria Margherita Rando

http://www.w3.org/2001/XMLSchema#string

Mariangela Antonelli

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases

Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam.

Effectiveness and safety of baclofen in the treatment of alcohol dependent patients.

High-dose baclofen for treatment-resistant alcohol dependence.

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review.

Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease.

Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection

Identification and management of alcohol withdrawal syndrome

P304

474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPSYT.2018.00474

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30327620

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

6174362

http://www.w3.org/2001/XMLSchema#string